Ovarian Cancer Research Alliance (@ocrahope) header
Ovarian Cancer Research Alliance (@ocrahope) profile picture

OCRA is the largest non-profit organization in the world combating ovarian and all gynecologic cancers.

DC and NYC
Joined January 2016
Photo by Ovarian Cancer Research Alliance (@ocrahope)Photo by Ovarian Cancer Research Alliance (@ocrahope)Photo by Ovarian Cancer Research Alliance (@ocrahope)Photo by Ovarian Cancer Research Alliance (@ocrahope)Photo by Ovarian Cancer Research Alliance (@ocrahope)Photo by Ovarian Cancer Research Alliance (@ocrahope)Photo by Ovarian Cancer Research Alliance (@ocrahope)Photo by Ovarian Cancer Research Alliance (@ocrahope)Photo by Ovarian Cancer Research Alliance (@ocrahope)Photo by Ovarian Cancer Research Alliance (@ocrahope)
As research progresses, so do treatments for gynecologic cancers. Join OCRA's free webinar on Nov. 18 to explore clinical trial findings that may support new FDA approvals, as well as encouraging early results for emerging therapies. Register at bit.ly/4zDdvKC This research, presented at the fall 2026 meetings of the European Society for Medical Oncology (ESMO) and the International Gynecologic Cancer Society (IGCS), will be discussed by UC San Diego Health’s Professor of Gynecologic Oncology Ramez Eskander, MD, and OCRA’s Senior Director of Treatment Access & Scientific Education Anne Mette Buhl, PhD (pictured here). @rne_md @IGCSociety @myESMO @UCSDHealth
1
2
104
This Cancer Biomarker Awareness Day, explore OCRA’s free videos about the growing role of biomarkers in gynecologic cancer care, including a new webinar with Sarah Ackroyd, MD, MPH, of University of Chicago Medicine: bit.ly/4k7ZQGF #CancerBiomarkerAwarenessDay @UChicagoMed
1
4
4
182
Join the FDA Oncology Center of Excellence for a free, two-part online workshop about new drugs being investigated as maintenance treatments for ovarian cancer. Register at bit.ly/4AMgYa7
Save the date! FDA's Oncology Center of Excellence is hosting a virtual workshop: "Maintenance Treatment for Ovarian Cancer: Weighing Benefit and Toxicity in an Evolving Landscape" on Nov. 12 & Nov. 19 at 12:30 PM ET. fda.gov/news-events/fda-meet…
1
80
Making decisions about end-of-life care can be an opportunity to honor personal values and priorities. OCRA is offering a free online workshop for gynecologic cancer patients, survivors & loved ones: bit.ly/4sOkuhc #AdvanceCarePlanning #GynCSM
2
1
48
The Living Lab is a secure, privacy-protected registry that combines data from people diagnosed with uterine or ovarian cancer to drive research breakthroughs. Participants can choose to contribute clinical data by sharing their health records, but doing so is completely optional. Learn more about ways to participate: bit.ly/3WlQHR0
1
69
Recent research points to a molecular link between ovarian aging and cancer. Findings from @NorthwesternU and @BuckInstitute could inform future studies into whether targeting the aging ovary therapeutically may lower ovarian cancer risk. #GynCSM #OvarianCancer news.northwestern.edu/storie…
2
84
Gynecologic cancers impact patients and their loved ones in many ways, with work, finances, and insurance all potentially affected. Join our partner @TriageCancer for a free online conference focused on strategies to navigate these legal and practical challenges. Register today: TriageCancer.org/Conferences #TriageTalks #GynCSM
56
Addressing practical matters in advance can help reduce stress when navigating a gynecologic cancer diagnosis. OCRA is offering a free online workshop focused on tools to prepare for future needs, including advance directives and disability insurance. Register: bit.ly/4iwknSF
1
64
Supporting a loved one through a gynecologic cancer diagnosis can bring new challenges. OCRA is here with resources for caregivers: bit.ly/4zp7scq #NationalFamilyCaregiversMonth #GynCSM
2
95
OCRA’s Advocate Leaders program is on track to have its biggest cohort yet. Plus, highlights from the 16th Biennial Rivkin Ovarian Cancer Research Symposium, a message of thanks to our community, resources for caregivers, and more. Get details at bit.ly/4zow7xP
1
111
Informed choices that align with patients’ personal goals can make all the difference when it comes to care. OCRA is offering a free series open to patients, survivors & loved ones, with the first session focused on determining care goals: bit.ly/4zlfKCk
2
79
Thanks to the generosity of all who give to OCRA, we can continue to offer support, advance research, and advocate for our community. Visit bit.ly/4f02Gda to learn about the many ways to donate, such as giving through stocks or IRAs.
1
1
79
Clear, current information is a crucial resource when navigating a diagnosis. An updated guide about ovarian cancer offered by the National Comprehensive Cancer Network (@NCCN) & proudly sponsored by OCRA is now available: bit.ly/4kkueNV
1
88
OCRA welcomed the opportunity to connect with attendees at the Race to End Women’s Cancer last month in Washington, DC, where we raised awareness about ovarian & gynecologic cancers. Thank you to our volunteers, all who stopped by our table, and the Foundation for Women’s Cancer for bringing so many of us together in support of our shared cause. @GYNCancer @ChemoBabe1
1
1
108
OCRA is thrilled to have brought together more than 375 ovarian cancer researchers, clinicians, and advocates to share findings at the 16th Biennial Rivkin Ovarian Cancer Research Symposium in Philadelphia: bit.ly/48dNKo3. Sessions explored a wide range of topics, including immuno-oncology, prevention and early detection, and rare subtypes. Thank you to all who attended! OCRA is grateful to the sponsors who made the Symposium possible, including Presenting Scientific Sponsor @AbbVie; Advocate Sponsors @AstraZeneca, Corcept Therapeutics, and @Genmab; and Contributor Sponsor @GSK. @Ronny_Drapkin @SophiaHLGe @GillianEHanley
1
8
167
Research advances are changing how biomarker tests are used to personalize gynecologic cancer care. Sarah Ackroyd, MD, MPH, of @UChicago, will discuss biomarkers and their role in treatment during OCRA’s free webinar on Oct. 28. Register: bit.ly/4Bp9SJt @SarahAckroydMD @UChicagoMed @UCCancerCenter
4
4
222
More than 700 people have joined the Living Lab. What does that actually mean for research? Living Lab Principal Investigator Leigh Pearce explains what’s already possible and what becomes possible as the registry grows: bit.ly/4dUlNoG
3
134
Have you or a loved one been diagnosed with FATWO (female adnexal tumor of Wolffian origin)? Connect with others who share this rare diagnosis during a special online meetup on Oct. 22 at 12:30 pm ET. For more information and the meeting link, contact [email protected]
95